Updated hourlyHourly refreshWed, Jul 15, 2026
Press Release Database
Recent press releases, indexed by topic.
Healthcare
Wednesday 15 July, 2026 Booking is now live for the Connected Lives training programme, with events in 20 locations across Scotland and online. The new training programme from Befriending Networks kicks off in Edinburgh on Tuesday 11 August and will continue until February 2027, visiting 20 towns and cities across Scotland. Four online sessions will also be available for those who are unable to attend in person. Connected Lives training is free and open to staff and volunteers at third sector organisations based in Scotland who want to feel more confident supporting people living with dementia. Research suggests that social isolation is a key risk factor for developing dementia. Alzheimer’s Research UK estimates that if everyone kept socially connected, there would be five fewer cases of d
Jul 15 · 13:16·Pressat
Healthcare
(PR-inside.com) ATLANTA, GA / ACCESS Newswire / July 15, 2026 / While remote work has become a permanent part of life for many professionals,Ankle & Foot Centers of Americais encouraging employees to pay closer attention to their foot health. Years after the work-from-home boom, podiatrists continue to see patients experiencing foot pain and other lower extremity issues related to prolonged sitting, reduced activity, and unsupportive footwear. Working from home often means spending long hours at a desk while barefoot or wearing slippers that lack proper arch support. Combined with hard flooring and decreased daily movement, these habits can contribute to conditions such ..
Jul 15 · 13:00·PR-Inside
Finance · Healthcare
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, July 15, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before...
Jul 15 · 12:55·PR Newswire
SaaS · Healthcare
— Peer-reviewed publication details RAG-17's robust translation from "bench to bedside," validating the proprietary SCAD™ delivery platform for CNS-targeted RNAi therapies — — First-in-Human trial met primary safety endpoints with no Serious Adverse Events (SAEs); demonstrated mean...
Jul 15 · 12:47·PR Newswire
Finance · AI
Issued on behalf of MindWalk Holdings Corp. MindWalk Holdings Corp. (NASDAQ: HYFT) heads into its fourth-quarter and full-year results with fresh index inclusion, an expanded patent estate, and AI-designed programs aimed at two of medicine's biggest frontiers: GLP-1 metabolic health and...
Jul 15 · 12:45·PR Newswire
SaaS · Healthcare
VANCOUVER, BC, July 15, 2026 /PRNewswire/ -- Intiveo, the patient engagement platform built for dental and oral surgery practices, today released its 2026 Dental Patient Engagement Report, a benchmark study drawn from communication and engagement data across more than 2,500 practices...
Jul 15 · 12:45·PR Newswire
Finance · Healthcare
TEL AVIV, Israel, July 15, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that its subsidiary NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous system disorders, announced the initiation of its Phase IIb clinical trial site at Hannover Medical School, Hanover, Germany (“MHH”), for SCI-110, its proprietary cannabinoid-based treatment candidate for Tourette Syndrome (TS) in adults.
Jul 15 · 12:41·GlobeNewswire
Healthcare
(PR-inside.com) MIAMI, FL / ACCESS Newswire / July 15, 2026 / Aimwell Partners Inc. (OTCID:AIMN), parent company of AimwellBio, today confirmed it is engaged in advanced discussions with an exclusive, referral-based life sciences capital markets network that connects biotechnology companies with institutional investors, banking relationships, strategic advisors, and other participants across the biotech investment ecosystem. The introduction originated through Christopher A. Jones, PhD, FRSM, Strategic Advisor to AimwellBio and one of the founding credentialed contributors to the company's Federated Health Intelligence Network. The company expects negotiations to conclude next week, at which time the counterparty and the scope of the relationship are anticipated ..
Jul 15 · 12:31·PR-Inside
Finance · Healthcare
(PR-inside.com) CEO Explains How Broad Patent Protection, Combined with First-Ever FDA IDE Approval, Positions enVVe® to Own a Multi-Billion-Dollar Venous Disease Market Watch the "What This Means" video here IRVINE, CA / ACCESS Newswire / July 15, 2026 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno Medical" or the "Company"), today announced that Robert Berman, Chief Executive Officer of enVVeno Medical participated in a Virtual Investor "What This Means" segment. As part of the segment, Mr. Berman discussed the Company's recent news announcing the issuance of the first U.S. Patent covering the company's enVVe system, further expanding its intellectual property portfolio and laying the groundwork to ..
Jul 15 · 12:31·PR-Inside
Finance · Healthcare
Alpha Tau Successfully Treats First Immunocompromised Patient with Recurrent Cutaneous Squamous Cell Carcinoma in its ADMIRE Study at Banner MD Anderson
Jul 15 · 12:30·GlobeNewswire
Healthcare
As Southern Utah temperatures climb, St. George foot and ankle clinic highlights how extreme heat can affect foot and ankle health and ways to lower risk. The post Foot & Ankle Center Warns Southern Utah Residents of Overlooked Summer Heat Risks first appeared on
Jul 15 · 12:28·PRUnderground
Healthcare
(PR-inside.com) MALMÖ, SE / ACCESS Newswire / July 15, 2026 / Ascelia Pharma (STO:ACE), a biotech company focused on improving the lives of people with rare cancer conditions, today announces that CFO Anton Hansson will be leaving the Company. In connection with this change and cost reduction initiatives, Ascelia Pharma is reducing its cost base while focusing on the path forward for Orviglance®. The changes support alignment of resources with Ascelia Pharma's current priorities, including regulatory interactions with the U.S. Food and Drug Administration ("FDA") and bringing Orviglance to patients. "Our focus is on the upcoming Type A meeting with the FDA where ..
Jul 15 · 12:05·PR-Inside